These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11457845)

  • 1. A catalytic loop within Pseudomonas aeruginosa exotoxin A modulates its transferase activity.
    Yates SP; Merrill AR
    J Biol Chem; 2001 Sep; 276(37):35029-36. PubMed ID: 11457845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation into the catalytic role for the tryptophan residues within domain III of Pseudomonas aeruginosa exotoxin A.
    Beattie BK; Prentice GA; Merrill AR
    Biochemistry; 1996 Dec; 35(48):15134-42. PubMed ID: 8952460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active site mutations of Pseudomonas aeruginosa exotoxin A. Analysis of the His440 residue.
    Han XY; Galloway DR
    J Biol Chem; 1995 Jan; 270(2):679-84. PubMed ID: 7822295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An enzyme-linked immunosorbent assay for the association of the catalytic domain of diphthamide-specific ribosyltransferases to eukaryotic elongation factor-2.
    Prentice GA; Merrill AR
    Anal Biochem; 1999 Aug; 272(2):216-23. PubMed ID: 10415091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active-site structure and enzymic mechanism.
    Wilson BA; Collier RJ
    Curr Top Microbiol Immunol; 1992; 175():27-41. PubMed ID: 1628498
    [No Abstract]   [Full Text] [Related]  

  • 6. Structure-function analysis of water-soluble inhibitors of the catalytic domain of exotoxin A from Pseudomonas aeruginosa.
    Yates SP; Taylor PL; Jørgensen R; Ferraris D; Zhang J; Andersen GR; Merrill AR
    Biochem J; 2005 Feb; 385(Pt 3):667-75. PubMed ID: 15458385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the diphthamide-containing loop within eukaryotic elongation factor 2 in ADP-ribosylation by Pseudomonas aeruginosa exotoxin A.
    Zhang Y; Liu S; Lajoie G; Merrill AR
    Biochem J; 2008 Jul; 413(1):163-74. PubMed ID: 18373493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The crystal structure of Pseudomonas aeruginosa exotoxin domain III with nicotinamide and AMP: conformational differences with the intact exotoxin.
    Li M; Dyda F; Benhar I; Pastan I; Davies DR
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9308-12. PubMed ID: 7568123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidation of eukaryotic elongation factor-2 contact sites within the catalytic domain of Pseudomonas aeruginosa exotoxin A.
    Yates SP; Merrill AR
    Biochem J; 2004 May; 379(Pt 3):563-72. PubMed ID: 14733615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward the elucidation of the catalytic mechanism of the mono-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exotoxin A.
    Armstrong S; Merrill AR
    Biochemistry; 2004 Jan; 43(1):183-94. PubMed ID: 14705944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro enzyme activation and folded stability of Pseudomonas aeruginosa exotoxin A and its C-terminal peptide.
    Beattie BK; Merrill AR
    Biochemistry; 1996 Jul; 35(28):9042-51. PubMed ID: 8703907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of synthetic peptides and site-specific antibodies to localize a diphtheria toxin sequence associated with ADP-ribosyltransferase activity.
    Olson JC
    J Bacteriol; 1993 Feb; 175(3):898-901. PubMed ID: 8423159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and immunochemical studies of proteolytic fragments of exotoxin A from Pseudomonas aeruginosa.
    Bourdenet S; Vacheron MJ; Guinand M; Michel G; Arminjon F
    Eur J Biochem; 1990 Sep; 192(2):379-85. PubMed ID: 2170123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refined crystallographic structure of Pseudomonas aeruginosa exotoxin A and its implications for the molecular mechanism of toxicity.
    Wedekind JE; Trame CB; Dorywalska M; Koehl P; Raschke TM; McKee M; FitzGerald D; Collier RJ; McKay DB
    J Mol Biol; 2001 Dec; 314(4):823-37. PubMed ID: 11734000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function analysis of exotoxin A proteins with mutations at histidine 426.
    Wick MJ; Cook JM; Iglewski BH
    Infect Immun; 1992 Mar; 60(3):1128-39. PubMed ID: 1541528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nature and character of the transition state for the ADP-ribosyltransferase reaction.
    Jørgensen R; Wang Y; Visschedyk D; Merrill AR
    EMBO Rep; 2008 Aug; 9(8):802-9. PubMed ID: 18583986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity.
    Gallant CV; Raivio TL; Olson JC; Woods DE; Storey DG
    Microbiology (Reading); 2000 Aug; 146 ( Pt 8)():1891-1899. PubMed ID: 10931893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of neutralizing antipeptide antibodies to the enzymatic domain of Pseudomonas aeruginosa exotoxin A.
    Elzaim HS; Chopra AK; Peterson JW; Goodheart R; Heggers JP
    Infect Immun; 1998 May; 66(5):2170-9. PubMed ID: 9573104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of exotoxin A-related protein of Pseudomonas aeruginosa lacking residues 225-412.
    Guidi-Rontani C
    FEMS Microbiol Lett; 1991 May; 64(1):103-9. PubMed ID: 1906825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation.
    Li M; Dyda F; Benhar I; Pastan I; Davies DR
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6902-6. PubMed ID: 8692916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.